Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 10, 2014 - Issue 5
Submit an article Journal homepage
1,389
Views
23
CrossRef citations to date
0
Altmetric
Reply Letter

Preventing non bacteremic pneumococcal pneumonia in older adults

Historical background and considerations for choosing between PCV13 and PPV23

David S Fedson Sergy Haut, FranceCorrespondence[email protected]
Pages 1322-1330 | Received 17 Feb 2014, Accepted 06 Apr 2014, Published online: 14 Apr 2014

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yang Wang, Jingxin Li, Yuxiao Wang, Wei Gu & Fengcai Zhu. (2018) Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Human Vaccines & Immunotherapeutics 14:4, pages 1003-1012.
Read now

Articles from other publishers (22)

Yuko Inoue, Upul Cooray, Miho Ishimaru, Kousuke Saito, Kenji Takeuchi, Katsunori Kondo & Jun Aida. (2023) Oral Self-Care, Pneumococcal Vaccination, and Pneumonia Among Japanese Older People, Assessed With Machine Learning. The Journals of Gerontology: Series A 78:11, pages 2170-2175.
Crossref
Feroze A. Ganaie, Jamil S. Saad, Stephanie W. Lo, Lesley McGee, Andries J. van Tonder, Paulina A. Hawkins, Juan J. Calix, Stephen D. Bentley & Moon H. Nahm. (2023) Novel pneumococcal capsule type 33E results from the inactivation of glycosyltransferase WciE in vaccine type 33F. Journal of Biological Chemistry 299:9, pages 105085.
Crossref
Feroze A. Ganaie, Jamil S. Saad, Stephanie W. Lo, Lesley McGee, Stephen D. Bentley, Andries J. van Tonder, Paulina Hawkins, Jeremy D. Keenan, Juan J. Calix & Moon H. Nahm. (2023) Discovery and Characterization of Pneumococcal Serogroup 36 Capsule Subtypes, Serotypes 36A and 36B. Journal of Clinical Microbiology 61:4.
Crossref
Angel Vila-Córcoles, Olga Ochoa-Gondar, Cinta de Diego-Cabanes, Eva M. Satué-Gracia, Verónica Torras-Vives, M. José Forcadell-Peris, Domingo Ribas-Seguí, Angel Vila-Rovira & Clara Rodríguez-Casado. (2023) Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018. Vaccine: X 13, pages 100264.
Crossref
Ellen Wolff, Jann Storsaeter, Åke Örtqvist, Pontus Naucler, Sofie Larsson, Tiia Lepp & Adam Roth. (2020) Cost-effectiveness of pneumococcal vaccination for elderly in Sweden. Vaccine 38:32, pages 4988-4995.
Crossref
Sarah Sterrett, Binghao J. Peng, Robert L. Burton, David C. LaFon, Andrew O. Westfall, Suddham Singh, Michael Pride, Annaliesa S. Anderson, Gregory C. Ippolito, Harry W SchroederJr.Jr., Moon H. Nahm, A. Krishna Prasad, Paul Goepfert & Anju Bansal. (2020) Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals. Vaccine 38:7, pages 1778-1786.
Crossref
Angel Vila-Corcoles, Immaculada Hospital, Olga Ochoa-Gondar, Eva Satue, Cinta de Diego, Angel Vila-Rovira, Frederic Gómez-Bertomeu, Xavier Raga & María Aragón. (2020) Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015–2016. Vaccine 38:5, pages 1170-1180.
Crossref
Fiona Ecarnot, Stefania Maggi & Jean-Pierre Michel. 2019. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Olga Ochoa-Gondar, Ángel Vila-Córcoles, Cinta de Diego, Eva Satué, Angel Vila-Rovira & María Aragón. (2018) Vacunación antineumocócica en adultos de Cataluña: coberturas y grado de adecuación a distintas guías de recomendaciones. Atención Primaria 50:9, pages 553-559.
Crossref
Hamid Latifi-Navid, Saeid Latifi-Navid, Behdad Mostafaiy, Sadegh Azimzadeh Jamalkandi & Ali Ahmadi. (2018) Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports. Scientific Reports 8:1.
Crossref
Soyoung Lee, Han Wool Kim, Ji Hyen Lee & Kyung-Hyo Kim. (2017) Functional immune responses to 11 non-PCV13 serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults. Vaccine 35:37, pages 4960-4965.
Crossref
Heather L. Sings. (2017) Pneumococcal conjugate vaccine use in adults – Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia. Vaccine 35:40, pages 5406-5417.
Crossref
S. Dirmesropian, J.G. Wood, C.R. MacIntyre, P. Beutels, P. McIntyre, R. Menzies, J.F. Reyes, C. Chen & A.T. Newall. (2017) Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians. Vaccine 35:34, pages 4307-4314.
Crossref
Gerhard Falkenhorst, Cornelius Remschmidt, Thomas Harder, Eva Hummers-Pradier, Ole Wichmann & Christian Bogdan. (2017) Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PLOS ONE 12:1, pages e0169368.
Crossref
David S. Fedson. (2016) PCV13 vaccination for older adults: Another view. Vaccine 34:38, pages 4466.
Crossref
Hannah Kraicer-Melamed, Shauna O’Donnell & Caroline Quach. (2016) The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis. Vaccine 34:13, pages 1540-1550.
Crossref
Livio Garattini, Anna Padula & Milene Rangel Da Costa. (2015) Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?. PharmacoEconomics 34:3, pages 221-224.
Crossref
Carolina J. Klett-Tammen, Gérard Krause, Linda Seefeld & Jördis J. Ott. (2016) Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health 16:1.
Crossref
Tamara Pilishvili & Nancy M. Bennett. (2015) Pneumococcal Disease Prevention Among Adults. American Journal of Preventive Medicine 49:6, pages S383-S390.
Crossref
Paul O. Gubbins & Chenghui Li. (2015) The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients. Current Infectious Disease Reports 17:12.
Crossref
Tamara Pilishvili & Nancy M. Bennett. (2015) Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine 33, pages D60-D65.
Crossref
Francesco Saverio Mennini, Andrea Marcellusi, Patrizia Giannantoni, Stefano Valente, Alessandro Rinaldi & Elisabetta Franco. (2015) Budget impact of pneumococcal vaccination in adults and elderly in Italy. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2:1, pages GRHTA.5000193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.